Bayer Aktiengesellschaft

F:BAYA Germany Drug Manufacturers - General
Market Cap
$39.13 Billion
€38.12 Billion EUR
Market Cap Rank
#1713 Global
#118 in Germany
Share Price
€9.70
Change (1 day)
-4.90%
52-Week Range
€4.78 - €12.40
All Time High
€23.66
About

Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast age… Read more

Bayer Aktiengesellschaft - Asset Resilience Ratio

Latest as of September 2025: 1.29%

Bayer Aktiengesellschaft (BAYA) has an Asset Resilience Ratio of 1.29% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
€1.34 Billion
Cash + Short-term Investments
Total Assets
€104.21 Billion
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (2016–2024)

This chart shows how Bayer Aktiengesellschaft's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Bayer Aktiengesellschaft's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents €0.00 0%
Short-term Investments €1.34 Billion 1.29%
Total Liquid Assets €1.34 Billion 1.29%

Asset Resilience Insights

  • Limited Liquidity: Bayer Aktiengesellschaft maintains only 1.29% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Bayer Aktiengesellschaft Industry Peers by Asset Resilience Ratio

Compare Bayer Aktiengesellschaft's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Zhejiang Int'L Group Co Ltd
SHE:000411
Drug Manufacturers - General 0.00%
Zhejiang Zhenyuan Share Co Ltd
SHE:000705
Drug Manufacturers - General 5.75%
Hunan Jingfeng Pharmaceutical
SHE:000908
Drug Manufacturers - General 0.38%
Hubei Guangji Pharmaceutical Co Ltd
SHE:000952
Drug Manufacturers - General 5.37%
Zhejiang Haisen Pharmaceutical Co. Ltd. A
SHE:001367
Drug Manufacturers - General 32.14%
Yifan Xinfu Pharmaceutical Co Ltd
SHE:002019
Drug Manufacturers - General 0.53%
Guangdong Jiaying Pharmaceutical Co Ltd
SHE:002198
Drug Manufacturers - General 0.00%
PharmGen Science Inc
KO:004720
Drug Manufacturers - General 0.16%

Annual Asset Resilience Ratio for Bayer Aktiengesellschaft (2016–2024)

The table below shows the annual Asset Resilience Ratio data for Bayer Aktiengesellschaft.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 1.71% €1.90 Billion €110.85 Billion -2.32pp
2023-12-31 4.03% €4.68 Billion €116.26 Billion +0.04pp
2022-12-31 3.99% €4.98 Billion €124.88 Billion +1.35pp
2021-12-31 2.64% €3.17 Billion €120.24 Billion -3.93pp
2020-12-31 6.57% €7.69 Billion €117.05 Billion +4.81pp
2019-12-31 1.76% €2.22 Billion €126.26 Billion +1.53pp
2018-12-31 0.23% €285.00 Million €126.28 Billion -1.79pp
2017-12-31 2.02% €1.52 Billion €75.09 Billion -2.27pp
2016-12-31 4.29% €3.52 Billion €82.24 Billion --
pp = percentage points